Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival

MLA

Benjamin M Ellingson, et al. “Objective Response Rate Targets for Recurrent Glioblastoma Clinical Trials Based on the Historic Association between Objective Response Rate and Median Overall Survival.” Neuro-Oncology, Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e914d6d9ca4c53a215697864f43aa434&authtype=sso&custid=ns315887.

APA

Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, Martin van den Bent, Michael A Vogelbaum, Gang Li, Shanpeng Li, Jiyoon Kim, Gilbert Youssef, Wolfgang Wick, Andrew B Lassman, Mark R Gilbert, John F de Groot, Michael Weller, Evanthia Galanis, & Timothy F Cloughesy. (2023). Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro-Oncology.

Chicago

Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, Martin van den Bent, Michael A Vogelbaum, Gang Li, Shanpeng Li, et al. 2023. “Objective Response Rate Targets for Recurrent Glioblastoma Clinical Trials Based on the Historic Association between Objective Response Rate and Median Overall Survival.” Neuro-Oncology, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e914d6d9ca4c53a215697864f43aa434&authtype=sso&custid=ns315887.